Modulation of granulocyte-endothelium interactions by antileukoproteinase: Inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium

Arthritis Research and Therapy

Volumn 8, Issue 4, 2006, Pages

  Sehnert, Bettina ^a   Gierer, Philip ^b   Ibrahim, Saleh ^b   Kühl, Anja ^b   Voll, Reinhard ^c   Nandakumar, Kutty Selva ^d   Holmdahl, Rikard ^d   Hallmann, Rupert ^e   Vollmar, Brigitte ^b   Burkhardt, Harald ^a,f  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CELL SEPARATION; DBA MOUSE; DRUG EFFECTS; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GRANULOCYTE; HUMAN; IMMUNOLOGY; KNEE; LEUKOCYTE; LEUKOCYTE ROLLING; METABOLISM; MOUSE; PHYSIOLOGY; SYNOVIUM; UPREGULATION; VASCULARIZATION; VENULE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CELL SEPARATION; COLLAGEN TYPE II; E-SELECTIN; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; INTERLEUKIN-1BETA; KNEE JOINT; LEUKOCYTE ROLLING; LEUKOCYTES; MICE; MICE, INBRED DBA; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; RECOMBINANT PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SYNOVIAL MEMBRANE; UP-REGULATION; VENULES;

EID: 34249714472     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1973     Document Type: Article

References (34)

1. Böhm B, Deutzmann R, Burkhardt H: Purification of a serineproteinase inhibitor from human articular cartilage. Identity with the acid-stable proteinase inhibitor of mucous secretions. Biochem J 1991, 274:269-273.
2. Böhm B, Aigner T, Kinne R, Burkhardt H: The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product. Eur J Biochem 1992, 207:773-779.
3. Jin FY, Nathan C, Radzioch D, Ding A: Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997, 88:417-426.
4. Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM: Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest 1997, 99:894-900.
5. Sehnert B, Cavcic A, Böhm B, Kalden JR, Nandakumar KS, Holmdahl R, Burkhardt H: AnMileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis. Arthritis Rheum 2004, 50:2347-2359.
6. Taggart CC, Greene CM, McElvaney NG, O'Neill S: Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced I?Ba degradation without affecting phosphorylation or ubiquitination. J Biol Chem 2002, 277:33648-33653.
7. Butcher EC: Leukocyte-endothelial Tell recognition: three (or more) steps to specificity and diversity. Cell 1991, 67 1033-1036.
8. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994, 76 301-314.
9. Mizgerd JP, Kubo H, Kutkoski GJ, Bhagwan SD, Scharffetter- Kochanek K, Beaudet AL, Doerschuk CM: Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CD11/CD18 revealed by CD18-deficient mice. J Exp Med 1997, 186:1357-1364.
10. Burkhardt H, Koller T, Engström A, Nandakumar KS, Turnay J, Kraetsch HG, Kalden JR, Holmdahl R: Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen- induced arthritis in the mouse. Arthritis Rheum 2002, 46:2339-2348.
11. Jung U, Ley K: Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol 1999, 162:6755-6762.
12. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995, 9 899-909.
13. Song X, Zeng L, Jin W, Thompson J, Mizel DE, Lei K, Billinghurst RC, Poole AR, Wahl SM: Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 1999, 190:535-542.
14. Lentsch AB, Yoshidome H, Warner RL, Ward PA, Edwards MJ: Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 1999, 117:953-961.
15. Schulte S, Unger C, Mo JA, Wendler O, Bauer E, Frischholz S, von der Mark K, Kalden JR, Holmdahl R, Burkhardt H: Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J Biol Chem 1998, 273:1551-1561.
16. Heinzel-Wieland R, Steffens GJ, Flohe L: Inhibitory characteristics and oxidant resistance of site specific variants of recombinant human antileukoproteinase (ALP). Biomed Biochim Acta 1991, 50 677-681.
17. Gierer P, Ibrahim S, Mittlmeier T, Koczan D, Moeller S, Landes J, Gradl G, Vollmar B: Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis. Arthritis Res Ther 2005, 7:R868-R876.
18. Veihelmann A, Szczesny G, Nolte D, Krombach F, Refior HJ, Messmer K: A novel model for the study of synovial microcirculation in the mouse knee joint in vivo. Res Exp Med (Berl) 1998, 198 43-54.
19. Hammel M, Weitz-Schmidt G, Krause A, Moll T, Vestweber D, Zerwes HG, Hallmann R: Species-specific and conserved epitopes on mouse and human E-selectin important for leukocyte adhesion. Exp Cell Res 2001, 269:266-274.
20. Sorokin L, Girg W, Gopfert T, Hallmann R, Deutzmann R: Expression of novel 400-kDa laminin chains by mouse and bovine endothelial cells. Eur J Biochem 1994, 223:603-610.
21. Brown KA, Vora A, Biggerstaff J, Edgell CJ, Oikle S, Mazure G, Taub N, Meager A, Hill T, Watson C, Dumonde DC: Application of an immortalized human endothelial cell line to the leucocyte: Endothelial adherence assay. J Immunol Methods 1993, 163:13-22.
22. Hildebrandt G, Maggiorella L, Rodel F, Rodel V, Willis D, Trott KR: Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro. Int J Radiat Biol 2002, 78:315-325.
23. Ghosh S, Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 1990, 344 678-682.
24. May MJ, Marienfeld RB, Ghosh S: Characterization of the IκBkinase NEMO binding domain. J Biol Chem 2002, 277:45992-46000.
25. Zhong H, Voll RE, Ghosh S: Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998:661-671.
26. Kunkel EJ, Ley K: Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996, 79:1196-1204.
27. Kunkel EJ, Dunne JL, Ley K: Leukocyte arrest during cytokinedependent inflammation in vivo. J Immunol 2000, 164:3301-3308.
28. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, Rot A: Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997, 91:385-395.
29. Shang XZ, Issekutz AC: Enhancement of monocyte transendothelial migration by granulocyte-macrophage colony-stimulating factor: requirement for chemoattractant and CD11a/CD18 mechanisms. Eur J Immunol 1999, 29:3571-3582.
30. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989, 243:1160-1165.
31. Read MA, Neish AS, Luscinskas F., Palombella VJ, Maniatis T, Collins T: The proteasome pathway is required for cytokineinduced endothelial-leukocyte adhesion molecule expression. Immunity 1995, 2:493-506.
32. Taggart CC, Greene CM, McElvaney NG, O'Neill S: Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IκBα degradation without affecting phosphorylation or ubiquitination. J Biol Chem 2002, 277:33648-33653.
33. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill SJ, McElvaney NG: Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding. J Exp Med 2005, 202:1659-1668.
34. Xia C, Ghosh S: NF-κB, an evolutionarily conserved mediator of immune and inflammatory responses. Adv Exp Med Biol 2005, 560:41-45.